Access the full text.
Sign up today, get DeepDyve free for 14 days.
N. Frickhofen, N. Young (1989)
Persistent parvovirus B19 infections in humans.Microbial pathogenesis, 7 5
C. Jones (1963)
REGIONAL CURARISATION. ANAESTHESIA FOR SURGERY OF THE KNEE-JOINT.Lancet, 2 7306
G. Kurtzman, B. Cohen, A. Field, R. Oseas, R. Blaese, N. Young (1989)
Immune response to B19 parvovirus and an antibody defect in persistent viral infection.The Journal of clinical investigation, 84 4
L. Anderson (1997)
Treatment and Prevention of Human Parvovirus B19 Disease, 20
A. Hemauer, A. Poblotzki, A. Gigler, P. Cassinotti, G. Siegl, Hans Wolf, S. Modrow (1996)
Sequence variability among different parvovirus B19 isolates.The Journal of general virology, 77 ( Pt 8)
P. Mortimer, N. Luban, J. Kelleher, B. Cohen (1983)
TRANSMISSION OF SERUM PARVOVIRUS-LIKE VIRUS BY CLOTTING-FACTOR CONCENTRATESThe Lancet, 322
Morfini Morfini, Longo Longo, Ferrini Ferrini, Azzi Azzi, Zakrewska Zakrewska, Ciappi Ciappi, Kolumban Kolumban (1992)
Hypoplastic anemia in a hemophiliac first infused with a solvent/detergent treated factor VIII concentrate: The role of human B19 parvovirusAmerican Journal of Hematology, 39
J. Saldanha, P. Minor (1996)
Detection of human parvovirus B19 DNA in plasma pools and blood products derived from these pools: implications for efficiency and consistency of removal of B19 DNA during manufactureBritish Journal of Haematology, 93
D Erdman, E. Durigon, Qi-Yun Wang, Larry Anderson (1996)
Genetic diversity of human parvovirus B19: sequence analysis of the VP1/VP2 gene from multiple isolates.The Journal of general virology, 77 ( Pt 11)
K. Umene, T. Nunoue (1993)
Partial nucleotide sequencing and characterization of human parvovirus B19 genome DNAs from damaged human fetuses and from patients with leukemiaJournal of Medical Virology, 39
Durigon Durigon, Erdman Erdman, Gary Gary, Pallansch Pallansch, Török Török, Anderson Anderson (1993)
Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNAJournal of Clinical Microbiology, 44
T. Török (1997)
Unusual Clinical Manifestations Reported in Patients with Parvovirus B19 Infection, 20
B. Cohen, A. Field, S. Gudnadóttir, S. Beard, J. Barbara (1990)
Blood donor screening for parvovirus B19.Journal of virological methods, 30 3
J. Gool, K. Went, B. Zegers (1976)
ACRODERMATITIS ENTEROPATHICA AND CELLULAR IMMUNE DEFICIENCYThe Lancet, 307
Gallinella Gallinella, Venturoli Venturoli, Gentilomi Gentilomi, Musiani Musiani, Zerbini Zerbini (1996)
Extent of sequence variability in a genomic region coding for capsid proteins of B19 parvovirusArchives in Virology, 140
A. Morey, G. Patou, S. Myint, K. Fleming (1992)
In vitro culture for the detection of infectious human parvovirus B19 and B19-specific antibodies using foetal haematopoietic precursor cells.The Journal of general virology, 73 ( Pt 12)
A. Grosse-Bley, A. Eis-Hübinger, R. Kaiser, J. Oldenburg, H. Brackmann, T. Schwarz, K. Schneweis (1994)
Serological and Virological Markers of Human Parvovirus B19 Infection in Sera of HemophiliacsThrombosis and Haemostasis, 72
M. Morfini, G. Longo, P. Ferrini, A. Azzi, C. Zakrewska, S. Ciappi, P. Kolumban (1992)
Letter to the editor: Hypoplastic anemia in a hemophiliac first infused with a solvent/detergent treated factor VIII concentrate: The role of human B19 parvovirusAmerican Journal of Hematology, 39
J. Kerr, M. Curran, J. Moore, P. Coyle, W. Fergusson (1995)
Persistent parvovirus B19 infectionThe Lancet, 345
D. Lyon, C. Chapman, Carol Martin, K. Brown, J. Clewley, A. Flower, V. Mitchell (1989)
SYMPTOMATIC PARVOVIRUS B19 INFECTION AND HEAT-TREATED FACTOR IX CONCENTRATEThe Lancet, 333
R. Shade, M. Blundell, S. Cotmore, P. Tattersall, C. Astell (1986)
Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisisJournal of Virology, 58
T. Finkel, D. Leung, R. Harbeck, E. Gelfand, T. Török, S. Zaki, L. Anderson, P. Ferguson, F. Saulsbury, E. Durigon, J. Hollister (1994)
Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?The Lancet, 343
F. Mcomish, P. Yap, A. Jordan, H. Hart, B. Cohen, P. Simmonds (1993)
Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reactionJournal of Clinical Microbiology, 31
To look for genetic changes in human parvovirus B19 that might be associated with chronic infection, we sequenced B19 DNA obtained from serum specimens collected over an approximately 1‐year period from a patient with systemic vasculitis. A comparison of the nucleotide sequences of the VP1/VP2 gene from four specimens revealed an abrupt change in the B19 genotype that coincided with initiation of intravenous immune globulin (IVIG) therapy. We suspect that one or more of the lots of IVIG administered to the patient were contaminated with B19. If true, this finding suggests that investigators must be careful in linking B19 infection to disease based on detection of B19 DNA in persons who have received multiple unit blood products. J. Med. Virol. 53:233–236, 1997. Published 1997 Wiley‐Liss, Inc. This article was prepared by a group consisting of both United States government employees and non‐United States government employees, and as such is subject to 17 U.S.C. Sec. 105.
Journal of Medical Virology – Wiley
Published: Nov 1, 1997
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.